<html>
  <head></head>
  <body>
    <div id="title">
      <h2>"Point in Time" Regulation Content</h2>
      <h4>
        <em> Pharmacy Operations and Drug Scheduling Act </em>
      </h4>
      <h3 style="line-height: 110%">Drug Schedules Regulation</h3>
      <h3>B.C. Reg. 9/98</h3>
    </div>
    <table cellpadding="3" cellspacing="0" class="tablestyle3">
      <tbody
        xmlns:act="http://www.gov.bc.ca/2013/legislation/act"
        xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table"
        xmlns:xlink="http://www.w3.org/1999/xlink"
      >
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Acetaminophen, when recommended for administration by intravenous
            injection
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Adenosine or its salts when sold or recommended for administration
            by intravenous injection
          </td>
        </tr>
        <tr>
          <td align="right" colname="c2" valign="top">1</td>
          <td colname="c2" valign="top">
            Adrenocortical hormones and their salts and derivatives
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
            , including but not limited to betamethasone dipropionate,
            betamethasone phosphate, betamethasone sodium, betamethasone
            valerate, budesonide, ciclesonide, clobetasone, cortisone,
            dexamethasone acetate, dexamethasone phosphate, dexamethasone
            sodium, difluprednate, fludrocortisone acetate, flunisolide,
            fluticasone furoate, fluticasone propionate, hydrocortisone
            aceponate, hydrocortisone acetate, hydrocortisone sodium,
            methylprednisolone acetate, methylprednisolone, methylprednisolone
            sodium, methylprednisolone succinate, mometasone furoate,
            prednisolone acetate, prednisolone phosphate, prednisolone sodium,
            prednisone, triamcinolone acetonide, triamcinolone hexacetonide
            (except
            <br />
            (a) hydrocortisone or hydrocortisone acetate, when sold as a single
            medicinal ingredient in a concentration that provides 1% or less
            hydrocortisone in preparations for topical use on the skin,
            <br />
            (b) hydrocortisone or hydrocortisone acetate, when sold in
            combination with any other non-prescription medicinal ingredient
            that provides 1% or less hydrocortisone in preparations for topical
            use on the skin,
            <br />
            (c) clobetasone butyrate, when sold in a concentration of 0.05% in
            cream preparations for topical use on the skin,
            <br />
            (d) fluticasone propionate, when sold for the treatment of allergic
            rhinitis in a nasal spray that delivers 50 mcg per metered spray for
            individuals 18 years of age and older),
            <br />
            (e) mometasone furoate for the treatment of allergic rhinitis in a
            nasal spray that delivers 50 mcg per spray for those 12 years of age
            and older, and
            <br />
            (f) triamcinolone acetonide in a nasal spray that delivers 55 mcg
            per spray for adults and children 12 years of age and older
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">Aluminum oxide</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Amobarbital</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Amphetamine</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">Anetholtrithione</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Antipyrine (except preparations for topical use)
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Antipyrine (except otic preparations)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">Antipyrine (for otic use)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Apomorphine and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Benzphetamine</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">Chlophedianol and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Cimetidine or its salts (except when sold in concentrations of 200
            mg or less per oral dosage unit and indicated for the treatment of
            heartburn)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Cimetidine or its salts, when sold in concentrations of 100 mg or
            less per oral dosage unit and indicated for the treatment of
            heartburn
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Copper chloride (cupric chloride) in injectable form for parenteral
            nutrition
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Deoxycholic acid and its salts, when used in an injectable form
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Deoxycholic acid and its salts (except when used in an injectable
            form)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1A</td>
          <td colname="c2" valign="top">Diacetylmorphine</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Dimenhydrinate and its salts (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Dimenhydrinate and its salts (for oral or rectal use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Electrolyte solutions (for oral rehydration)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Ephedrine and its salts in combination products (in preparations
            containing no more than 8 mg per unit dose, with a label
            recommending no more than 8 mg/dose or 32 mg/day and for use for no
            more than 7 days, and indicated for nasal congestion)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Ephedrine and its salts in single entity products (in preparations
            containing no more than 8 mg per unit dose, with a label
            recommending no more than 8 mg/dose or 32 mg/day and for use for no
            more than 7 days, and indicated for nasal congestion)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Glycopyrrolate or its salts (except glycopyrronium bromide,
            including but not limited to glycopyrrolate, when used orally or for
            inhalation)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Glycopyrronium bromide (including but not limited to glycopyrrolate,
            when used orally or for inhalation)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Hyoscine and its salts and derivatives [scopolamine] (except
            hyoscine butylbromide, when recommended for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Hyoscine butylbromide (when recommended for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Ketamine and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Levonorgestrel (when sold in concentrations of 1.5 mg or less per
            oral dosage unit, except when labelled to be taken as a single dose
            of 1.5 mg and in package sizes containing no more than 1.5 mg
            levonorgestrel, packaged and labelled for emergency contraception)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Levonorgestrel (when sold in concentrations of 1.5 mg or less per
            oral dosage unit to be taken as a single dose of 1.5 mg, packaged
            and labelled for emergency contraception, in package sizes
            containing no more than 1.5 mg of levonorgestrel)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Lidocaine (when in a preparation containing an equal amount of
            tetracaine and recommended for topical use on the skin, in
            concentrations of 7% or higher)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Magnesium sulfate (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Methamphetamine</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Mifepristone or its derivatives</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Nicotinic acid [niacin] in extended-release formulations, except
            when sold in a modified-release oral dosage form that provides 500
            mg or more per dosage unit or per daily dose
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Phendimetrazine and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Phenmetrazine and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Potassium citrate (when recommended for the treatment of renal
            tubular acidosis and kidney stones)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Potassium salts (in oral preparations containing more than 5 mmol
            per single dose, except
            <br />
            (a) potassium bromide,
            <br />
            (b) potassium gluconate when sold or recommended for administration
            to cats,
            <br />
            (c) potassium para-aminobenzoate, and
            <br />
            (d) potassium citrate when recommended for the treatment of renal
            tubular acidosis and kidney stones)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Pseudoephedrine and its salts and preparations in combination
            products
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Pseudoephedrine and its salts and preparations in single entity
            products
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Salicylic acid (when sold in topical formulations containing
            salicylic acid at concentrations greater than 20% or with a pH less
            than 3.0, or both, except when sold to be applied to warts, corns or
            calluses)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Salicylic acid (when sold to be applied to warts, corns or calluses
            in topical preparations in concentrations greater than 40%)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Sodium acetate (for parenteral use)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Sodium chloride (single ingredient solutions for parenteral or
            ophthalmic use in concentrations of more than 0.9%) [NOTE: Does not
            apply to contact lens solutions intended to be rinsed off prior to
            insertion into eye]
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Sodium phosphate (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Tetracaine (when in a preparation containing an equal amount of
            lidocaine and recommended for topical use on the skin, in
            concentrations of 7% or higher)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Ulipristal or its salts or derivatives (including but not limited to
            ulipristal acetate)
          </td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
